Lorazepam Prices June 2023
Product
|
Category |
Region |
Price |
Lorazepam |
Pharma API |
USA |
838 USD/MT |
Lorazepam |
Pharma API |
Germany |
858 USD/MT |
The prices of lorazepam in the United States for Q2 2023 reached 838 USD/MT in June 2023. Similarly, the prices in Germany reached 858 USD/MT.
Lorazepam Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Lorazepam Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of lorazepam pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of lorazepam at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of lorazepam price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing lorazepam price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Lorazepam Market Analysis
The global lorazepam market size reached US$ 628.1 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 830.3 Million, at a projected CAGR of 3.15% during 2023-2032.
- Globally, the prevalence of anxiety disorders and insomnia is on the rise, which represents one of the main factors propelling the lorazepam market. According to the WORLD HEALTH ORGANIZATION (WHO), anxiety disorders affect 301 million people in 2019. Moreover, according to ANXIETY AND DEPRESSION ASSOCIATION OF AMERICA, SAD affects 15 Million adults or 7.1% of the U.S. population. Hence, a benzodiazepine, lorazepam is frequently recommended to treat anxiety disorders because of how well it calms the central nervous system. In addition, the escalating demand for Lorazepam can be also attributed to rising acceptance of seeking medical attention for mental health difficulties and rising awareness and diagnosis of mental health conditions.
- Another major reason propelling the lorazepam market is the aging global population. According to the WHO, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Moreover, by 2030, 1 in 6 people in the world will be aged 60 years or over. Lorazepam is frequently used to treat anxiety and sleep disturbances, which are more common among older persons. As older patients frequently have coexisting medical diseases and chronic illnesses that worsen anxiety and sleep disruptions, it will continue to escalate the demand for lorazepam and other similar drugs.
- Technological advancements and innovations in pharmaceutical formulations are further propelling the market. The pharmaceutical market in India was estimated by IMARC GROUP to be worth US$ 54.6 billion in 2023. The report projects that the market will expand at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2032, when it reaches US$ 163.1 billion. With this expanding pharmaceutical industry, key players are focusing on developing improved formulations of lorazepam that offer better efficacy, safety, and patient compliance.
Lorazepam News
The report covers the latest developments, updates, and trends impacting the global lorazepam market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in lorazepam production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the lorazepam price trend.
Latest developments in the lorazepam industry:
- In May 2024, Hikma has lorazepam 2 mg/mL 1 mL vials on back order and the company estimates a release date of early-May 2024. The 2 mg/mL 10 mL vials and 4 mg/mL 1 mL vials on back order and the company cannot estimate a release date. There are short-dated 4 mg/mL 10 mL vials available with an expiration date of < October 2024.
Product Description
Lorazepam is a member of the benzodiazepine class of drugs which is frequently given to treat anxiety disorders, sleeplessness, and other ailments. It increases the brain neurotransmitter that has a calming effect called gamma-aminobutyric acid (GABA) activity. This produces combined effects of sedation, induces sleep, and lowers anxiety. Due to its sedative properties, Lorazepam is also prescribed for the short-term treatment of insomnia. It helps in decreasing the time it takes to fall asleep and increasing the duration of sleep. Besides, in emergency settings, Lorazepam is utilized for the management of acute seizures, including status epilepticus. Its quick action helps in controlling seizure activity effectively. Moreover, it is available in a number of forms, such as injections, tablets, and oral solutions.
Regional Coverage
The report provides a detailed analysis of the lorazepam market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the lorazepam price trend.
Global Lorazepam Price
The report offers a holistic view of the global lorazepam pricing trends in the form of lorazepam price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of lorazepam but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed lorazepam demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Lorazepam Price
European lorazepam prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed lorazepam price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North American Lorazepam Price
The analysis of lorazepam prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific lorazepam historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and African Lorazepam Price
The report explores the lorazepam pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on lorazepam prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Lorazepam Price
The lorazepam pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This lorazepam price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin American Lorazepam Price
The analysis of lorazepam prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Lorazepam |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Lorazepam Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of lorazepam pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting lorazepam price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The lorazepam price charts ensure our clients remain at the forefront of the industry.